Table 4.

Factors associated with relapse after bone marrow transplantation for myelodysplasia in multivariate analysis

VariablesRelative risk (95% CI)P
Blasts in bone marrow before transplantation4-150   
 (1)  Less than 5% 1.00 Poverall < .0001 
 (2)  5%-20% 2.9  (1.7-4.9) P12 < .0001  
 (3)  More than 20% 6.3  (3.4-11.6) P13 < .0001 
 (4)  Unknown 2.5  (1.3-4.9) P140 = .0082  
IPSS at diagnosis4-153   
 (1)  High risk 1.00  
 (2)  Intermediate/low risk 0.5  (0.3-0.8) P12 = .0061 
 (3)  Unknown 0.4  (0.2-0.7) P13 = .0033  
GVHD prophylaxis   
 (1)  Non T-cell depletion 1.00  
 (2)  T-cell depletion 1.8  (1.0-3.2) P = .0361 
VariablesRelative risk (95% CI)P
Blasts in bone marrow before transplantation4-150   
 (1)  Less than 5% 1.00 Poverall < .0001 
 (2)  5%-20% 2.9  (1.7-4.9) P12 < .0001  
 (3)  More than 20% 6.3  (3.4-11.6) P13 < .0001 
 (4)  Unknown 2.5  (1.3-4.9) P140 = .0082  
IPSS at diagnosis4-153   
 (1)  High risk 1.00  
 (2)  Intermediate/low risk 0.5  (0.3-0.8) P12 = .0061 
 (3)  Unknown 0.4  (0.2-0.7) P13 = .0033  
GVHD prophylaxis   
 (1)  Non T-cell depletion 1.00  
 (2)  T-cell depletion 1.8  (1.0-3.2) P = .0361 
F4-150

P23 = .0069;P24 = .6095;P34 = .0083.

3 df.

F4-153

P of intermediate versus low IPSS score at diagnosis: .1699.

P12 = probability of testing (1) = (2); P13 = probability of testing (1) = (3); P14 = probability of testing (1) = (4).

Close Modal

or Create an Account

Close Modal
Close Modal